000 -LEADER |
fixed length control field |
04004nam a22004095i 4500 |
003 - CONTROL NUMBER IDENTIFIER |
control field |
OSt |
005 - DATE AND TIME OF LATEST TRANSACTION |
control field |
20140310150238.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION |
fixed length control field |
cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
fixed length control field |
121116s2013 xxu| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
International Standard Book Number |
9781461456476 |
|
978-1-4614-5647-6 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER |
Classification number |
RC261-271 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER |
Classification number |
614.5999 |
Edition number |
23 |
264 #1 - |
-- |
New York, NY : |
-- |
Springer New York : |
-- |
Imprint: Springer, |
-- |
2013. |
912 ## - |
-- |
ZDB-2-SBL |
100 1# - MAIN ENTRY--PERSONAL NAME |
Personal name |
Ahmad, Aamir. |
Relator term |
editor. |
245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
Title |
Breast Cancer Metastasis and Drug Resistance |
Medium |
[electronic resource] : |
Remainder of title |
Progress and Prospects / |
Statement of responsibility, etc |
edited by Aamir Ahmad. |
300 ## - PHYSICAL DESCRIPTION |
Extent |
XI, 413 p. 59 illus., 45 illus. in color. |
Other physical details |
online resource. |
505 0# - FORMATTED CONTENTS NOTE |
Formatted contents note |
Preface -- Breast Cancer Statistics -- Epidemiology of Breast Cancer in Women -- The Complexities of Racial Disparity in Breast Cancer -- Major signaling pathways involved in Breast Cancer -- Breast Cancer Heterogeneity in Primary and Metastatic Disease -- Understanding Triple-negative Breast Cancer -- The biology of the deadly love connection between obesity, diabetes and breast cancer -- Progression of Early Breast Cancer to an Invasive Phenotype -- Pre-clinical modeling of breast cancer – which model to choose? -- Modeling breast cancer progression in 4-D -- Bone Metastasis of Breast Cancer -- Cellular and Molecular Mechanisms Involved in Breaching of The Blood-Brian Barrier By Circulating Breast Cancer Cells -- Resistance to Anthracyclines and Taxanes in Breast cancer -- Understanding of Tamoxifen Resistance of Breast Cancer based on Integrative Bioinformatics Approaches -- Current understanding of drug resistance mechanisms and therapeutic targets in HER2 overexpressing breast cancers -- Platinum and ruthenium complexes for the therapy of breast cancer diseases.-Development of Notch Pathway Inhibitors for Cancer Therapy -- Systems Biology Approaches in Breast Cancer Studies -- Epigenetic Factors in Breast Cancer Progression -- Breast Cancer Stem Cells and miRNAs -- Breast Cancer Stem Cells: responsible for therapeutic resistance and relapse? -- MicroRNAs in Breast Cancer Research: Progress and Promise -- Index. |
520 ## - SUMMARY, ETC. |
Summary, etc |
This comprehensive book on breast cancer brings together some of the leading experts in an attempt to better understand breast cancer disease, the factors that make it lethal and current research progress, integrating both basic research with clinical implications. This volume covers the following core issues: i) heterogeneity in breast cancer – statistics, epidemiology, breast cancer subtypes, racial disparity and the associated challenges, ii) available and upcoming model systems in breast cancer research, iii) breast cancer metastasis to bones and brain, iv) drug resistance mechanisms in breast cancer against targeted therapies and v) recent developments in breast cancer research – state of current research directions / technologies / approaches. With its comprehensive coverage of topics related to breast cancer, this volume is expected to have a very wide appeal. It serves as an excellent source of reference for students/beginning researchers just setting foot in the field and interested in getting to know all the aspects of this disease. The book should also appeal to advanced and senior researchers by bringing everyone up-to-date with the most current knowledge on various breast cancer topics of utmost relevance |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
Topical term or geographic name as entry element |
Medicine. |
|
Topical term or geographic name as entry element |
Oncology. |
|
Topical term or geographic name as entry element |
Drug interactions. |
|
Topical term or geographic name as entry element |
Biomedicine. |
|
Topical term or geographic name as entry element |
Cancer Research. |
|
Topical term or geographic name as entry element |
Drug Resistance. |
710 2# - ADDED ENTRY--CORPORATE NAME |
Corporate name or jurisdiction name as entry element |
SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY |
Title |
Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY |
Display text |
Printed edition: |
International Standard Book Number |
9781461456469 |
856 40 - ELECTRONIC LOCATION AND ACCESS |
Uniform Resource Identifier |
http://dx.doi.org/10.1007/978-1-4614-5647-6 |
942 ## - ADDED ENTRY ELEMENTS (KOHA) |
Source of classification or shelving scheme |
|
Item type |
E-Book |